I agree that this site is using cookies. You can find further informations here.
X
Bassi, Simona
184  results:
Search for persons X
?
1

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Malagola, Michele ; Polverelli, Nicola ; Martino, Massimo...
Transplantation Direct.  9 (2023)  3 - p. e1451 , 2023
Link: https://doi.org/10.1097/..
 
?
2

GITMO Registry Study on Allogeneic Transplantation in Patie..:

Malagola, Michele ; Polverelli, Nicola ; Rubini, Vicky...
Transplantation and Cellular Therapy.  28 (2022)  2 - p. 96.e1-96.e11 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Mixed T cell CHIMERISM in bone marrow at day+30 after allog..:

Guidotti, Samantha ; Bassi, Simona ; Rossi, Angela...
European Journal of Haematology.  109 (2022)  1 - p. 83-89 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Corrigendum to "Ibrutinib as a bridge to transplant in high..:

Arcari, Annalisa ; Bassi, Simona ; Pochintesta, Lara...
Leukemia Research Reports.  11 (2019)  - p. 51 , 2019
Link: https://doi.org/10.1016/..
 
?
5

A single dose of Pegfilgrastim versus daily Filgrastim to e..:

Bassi, Simona ; Rabascio, Cristina ; Nassi, Luca...
Transfusion and Apheresis Science.  43 (2010)  3 - p. 321-326 , 2010
Link: https://doi.org/10.1016/..
 
?
6

Ibrutinib as a bridge to transplant in high-risk chronic ly..:

Annalisa, Arcari ; Simona, Bassi ; Lara, Pochintesta...
Leukemia Research Reports.  8 (2017)  - p. 21-23 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Malagola, Michele ; Polverelli, Nicola ; Martino, Massimo...
info:eu-repo/semantics/altIdentifier/pmid/36845852.  , 2023
Link: https://hdl.handle.net/2..
 
?
8

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Malagola, Michele ; Polverelli, Nicola ; Martino, Massimo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949804/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIE..:

Malagola, Michele ; Polverelli, Nicola ; Rubini, Vicky...
info:eu-repo/semantics/altIdentifier/pmid/34818581.  , 2021
Link: http://hdl.handle.net/23..
 
?
10

Ibrutinib as a bridge to transplant in high-risk chronic ly..:

Arcari Annalisa ; Bassi Simona ; Pochintesta Lara...
http://www.sciencedirect.com/science/article/pii/S2213048917300262.  , 2017
Link: https://doi.org/10.1016/..
 
?
11

Safety and efficacy of granulocyte colony-stimulating facto..:

Bassi, Simona ; Stroppa, Elisa M ; Moroni, Carlo F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614302/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
12

Purging e alte dosi di chemioterapia con reinfusione di cel..:

Bassi, Simona
http://amsdottorato.unibo.it/807/1/Tesi_Bassi_Simona.pdf.  , 2008
Link: http://amsdottorato.unib..
 
?
13

Busulfan or Treosulfan Conditioning Platform for Allogeneic..:

Michele Malagola, MD ; Nicola Polverelli, MD ; Massimo Martino, MD...
http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001451.  , 2023
Link: https://doi.org/10.1097/..
 
?
14

Ibrutinib as a bridge to transplant in high-risk chronic ly..:

Annalisa, Arcari ; Simona, Bassi ; Lara, Pochintesta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717301/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

Impact of age on the outcome of patients with chronic myelo..:

Marilina Amabile ; Simona Bassi ; Ilaria Iacobucci...
url:https://www.openaccessrepository.it/communities/itmirror.  , 2007
Link: https://www.openaccessre..
 
1-15